Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study Shows Circulating Tumor Cell Chips Track Cancer Drug Response

This article was originally published in The Gray Sheet

Executive Summary

Circulating tumor cell chips show promise as monitors of cancer therapy response in a study led by the Massachusetts General Hospital Cancer Center published July 2 in the New England Journal of Medicine
Advertisement

Related Content

J&J’s Veridex To Lead Development Of Next-Gen Cancer Diagnostic
J&J’s Veridex To Lead Development Of Next-Gen Cancer Diagnostic
Circulating Tumor Cell Dx Is Technology To Watch In 2009 – Cleveland Clinic
Circulating Tumor Cell Dx Is Technology To Watch In 2009 – Cleveland Clinic
Circulating Tumor Cell Detection A Technology To Watch In 2009 – Cleveland Clinic
Abbott Diagnostics Unit Teams Up With Big Pharma On Companion Test
Abbott Diagnostics Unit Teams Up With Big Pharma On Companion Test
Advertisement
UsernamePublicRestriction

Register

MT026309

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel